open access

Vol 22, No 5 (2017)
Original research articles
Published online: 2017-09-01
Submitted: 2016-07-08
Get Citation

Malignant pleural mesothelioma – Pleural cavity irradiation after decortication with helical tomotherapy

Semi B. Harrabi, Stefan A. Koerber, Sebastian Adeberg, Sonja Katayama, Klaus Herfarth, Juergen Debus, Florian Sterzing
DOI: 10.1016/j.rpor.2017.07.006
·
Rep Pract Oncol Radiother 2017;22(5):402-407.

open access

Vol 22, No 5 (2017)
Original research articles
Published online: 2017-09-01
Submitted: 2016-07-08

Abstract

Background

Malignant pleural mesothelioma (MPM) is a rare and aggressive disease that poses a treatment challenge in spite of recent technical developments. The aim of this retrospective analysis is to assess the feasibility of administering intensity-modulated radiotherapy (IMRT) to the pleural cavity using helical tomotherapy in patients who had undergone pleurectomy/decortication (P/D) and also the resulting toxicity levels.

Patients and methods

Ten patients who had MPM and had undergone P/D were treated with pleural cavity irradiation that included a median dose of 52.2[[ce:hsp sp="0.25"/]]Gy using helical tomotherapy. The median age of the patients was 53 years (31–74). In addition to clinical and diagnostic findings from regular follow-up examinations, we evaluated the dose distribution for other organs at risk to assess treatment in relation to toxicity, with special regard for the underlying intact lung.

Results

The mean lung dose on the treatment site was 32.8[[ce:hsp sp="0.25"/]]Gy (±6.8). The V20[[ce:hsp sp="0.25"/]]Gy was 71.7% (±17.2). No treatment-related toxicity that exceeded grade III according to common toxicity criteria (CTC) was observed. Median progression-free survival (PFS) was 13 months with a median overall survival (OAS) of 19 months.

Conclusion

The findings of this analysis provide data indicating that sparing the underlying lung in patients with MPM after P/D is not only feasible with helical tomotherapy, but that this treatment also causes reasonably few side effects.

Abstract

Background

Malignant pleural mesothelioma (MPM) is a rare and aggressive disease that poses a treatment challenge in spite of recent technical developments. The aim of this retrospective analysis is to assess the feasibility of administering intensity-modulated radiotherapy (IMRT) to the pleural cavity using helical tomotherapy in patients who had undergone pleurectomy/decortication (P/D) and also the resulting toxicity levels.

Patients and methods

Ten patients who had MPM and had undergone P/D were treated with pleural cavity irradiation that included a median dose of 52.2[[ce:hsp sp="0.25"/]]Gy using helical tomotherapy. The median age of the patients was 53 years (31–74). In addition to clinical and diagnostic findings from regular follow-up examinations, we evaluated the dose distribution for other organs at risk to assess treatment in relation to toxicity, with special regard for the underlying intact lung.

Results

The mean lung dose on the treatment site was 32.8[[ce:hsp sp="0.25"/]]Gy (±6.8). The V20[[ce:hsp sp="0.25"/]]Gy was 71.7% (±17.2). No treatment-related toxicity that exceeded grade III according to common toxicity criteria (CTC) was observed. Median progression-free survival (PFS) was 13 months with a median overall survival (OAS) of 19 months.

Conclusion

The findings of this analysis provide data indicating that sparing the underlying lung in patients with MPM after P/D is not only feasible with helical tomotherapy, but that this treatment also causes reasonably few side effects.

Get Citation

Keywords

Malignant pleural mesothelioma; Pleural cavity irradiation; Pleurectomy/decortication; Tomotherapy

About this article
Title

Malignant pleural mesothelioma – Pleural cavity irradiation after decortication with helical tomotherapy

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 22, No 5 (2017)

Pages

402-407

Published online

2017-09-01

DOI

10.1016/j.rpor.2017.07.006

Bibliographic record

Rep Pract Oncol Radiother 2017;22(5):402-407.

Keywords

Malignant pleural mesothelioma
Pleural cavity irradiation
Pleurectomy/decortication
Tomotherapy

Authors

Semi B. Harrabi
Stefan A. Koerber
Sebastian Adeberg
Sonja Katayama
Klaus Herfarth
Juergen Debus
Florian Sterzing

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl